Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
J Intern Med. 2012 Sep;272(3):257-66. doi: 10.1111/j.1365-2796.2011.02505.x. Epub 2012 Jan 12.
Echolucent plaques are related to a higher cardiovascular risk. Studies to investigate the relationship between echolucency and cardiovascular risk in the early stages of atherosclerosis are limited. We studied the relationship between cardiovascular risk factors and echolucency of the carotid intima-media in low-risk individuals.
Data were analysed from the Measuring Effects on Intima-Media Thickness: an Evaluation of Rosuvastatin (METEOR) study, a randomized placebo-controlled trial including 984 individuals which showed that rosuvastatin attenuated the rate of change of carotid intima-media thickness (CIMT). In this post hoc analysis, duplicate baseline ultrasound images from the far wall of the left and right common carotid arteries were used for the evaluation of the echolucency of the carotid intima-media, measured by grey-scale median (GSM) on a scale of 0-256. Low GSM values reflect echolucent, whereas high values reflect echogenic structures. The relationship between baseline GSM and cardiovascular risk factors was evaluated using linear regression models.
Mean baseline GSM (± SD) was 84 ± 29. Lower GSM of the carotid intima-media was associated with older age, high body mass index (BMI) and low levels of high-density lipoprotein cholesterol (HDL-C) [beta -4.49, 95% confidence interval (CI) -6.50 to -2.49; beta -4.51, 95% CI -6.43 to -2.60; beta 2.45, 95% CI 0.47 to 4.42, respectively]. Common CIMT was inversely related to GSM of the carotid intima-media (beta -3.94, 95% CI -1.98 to -5.89).
Older age, high BMI and low levels of HDL-C are related to echolucency of the carotid intima-media. Hence, echolucency of the carotid intima-media may be used as a marker of cardiovascular risk profile to provide more information than thickness alone.
回声衰减斑块与更高的心血管风险相关。在动脉粥样硬化的早期阶段,研究回声衰减与心血管风险之间关系的研究有限。我们研究了低危个体的心血管危险因素与颈动脉内膜中层回声衰减之间的关系。
数据分析来自于评估瑞舒伐他汀对颈动脉内膜中层厚度影响的研究(METEOR),这是一项随机安慰剂对照试验,纳入了 984 名个体,结果表明瑞舒伐他汀可减缓颈动脉内膜中层厚度(CIMT)的变化率。在这个事后分析中,使用灰阶中位数(GSM)在 0-256 的范围内来评估颈动脉内膜中层的回声衰减,对来自左、右颈总动脉远侧壁的重复基线超声图像进行评估。较低的 GSM 值反映回声衰减,而较高的值则反映回声增强结构。使用线性回归模型评估基线 GSM 与心血管危险因素之间的关系。
平均基线 GSM(±SD)为 84 ± 29。颈动脉内膜中层较低的 GSM 与年龄较大、高体重指数(BMI)和低水平高密度脂蛋白胆固醇(HDL-C)相关[β-4.49,95%置信区间(CI)-6.50 至-2.49;β-4.51,95%CI-6.43 至-2.60;β2.45,95%CI0.47 至 4.42]。普通 CIMT 与颈动脉内膜中层的 GSM 呈负相关(β-3.94,95%CI-1.98 至-5.89)。
年龄较大、高 BMI 和低水平的 HDL-C 与颈动脉内膜中层的回声衰减有关。因此,颈动脉内膜中层的回声衰减可作为心血管风险状况的标志物,提供比厚度单独提供的更多信息。